NATALIE BALES: Open Payments
NPI 1003648312 · SPRING, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$493 in 18 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $19 · 2025 $493
Food & beverage: $468Travel & lodging: $25
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $156 |
| Novo Nordisk Inc | 4 | $85 |
| Radius Health, Inc. | 2 | $55 |
| ABBVIE INC. | 2 | $49 |
| Lilly USA, LLC | 2 | $41 |
| Stryker Corporation | 1 | $25 |
| Exact Sciences Corporation | 1 | $24 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
| Mannkind Corporation | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $19 |
Products named: JARDIANCE, Tymlos, UBRELVY, MOUNJARO, Wegovy, SYSTEM 9 CD NXT, Cologuard Collection Kit, AIRSUPRA.
Industry payments across TX — which companies pay providers there.
